Advertisement

Oral Manifestations of Gastrointestinal Disorders

      Dentists are often the first health care professionals to identify a systemic disease. Oral manifestations can be the initial indication of gastrointestinal (GI) disease and allow for an early diagnosis, treatment, and improved prognosis.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      References

        • U.S. Department of Health and Human Services
        Oral Health in America: A Report of the Surgeon General.
        U.S. Department of Health and Human Services, National Institute of Dental and Craniofacial Research, National Institutes of Health, Rockville (MD)2000
        • Swinson B.
        • Witherow H.
        • Norris P.
        • et al.
        Oral manifestations of systemic diseases.
        Hosp Med. 2004; 65: 92-99
        • Daley T.D.
        • Armstrong J.E.
        Oral manifestations of gastrointestinal diseases.
        Can J Gastroenterol. 2007; 21: 241-244
        • Islam N.M.
        • Bhattacharyya I.
        • Cohen D.M.
        Common oral manifestations of systemic disease.
        Otolaryngol Clin North Am. 2011; 44 (vi): 161-182
        • Jurge S.
        • Hegarty A.M.
        • Hodgson T.
        Orofacial manifestations of gastrointestinal disorders.
        Br J Hosp Med (Lond). 2014; 75: 497-501
        • Fumagalli L.A.
        • Gatti H.
        • Armano C.
        • et al.
        Oral Pathology unmasking gastrointestinal disease.
        J Dent Health Oral Disord Ther. 2016; 5: 00170
        • Dundar A.
        • Sengun A.
        Dental approach to erosive tooth wear in gastroesophageal reflux disease.
        Afr Health Sci. 2014; 14: 481-486
        • Chi A.C.
        • Neville B.W.
        • Krayer J.W.
        • et al.
        Oral manifestations of systemic disease.
        Am Fam Physician. 2010; 82: 1381-1388
        • Vinesh E.
        • Masthan K.
        • Kumar M.S.
        • et al.
        A clinicopathologic study of oral changes in gastroesophageal reflux disease, gastritis, and ulcerative colitis.
        J Contemp Dent Pract. 2016; 17: 943-947
        • Vakil N.
        • van Zanten S.V.
        • Kahrilas P.
        • et al.
        The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus.
        Am J Gastroenterol. 2006; 101: 1900-1920
        • Roesch-Ramos L.
        • Roesch-Dietlen F.
        • Remes-Troche J.M.
        • et al.
        Dental erosion, an extraesophageal manifestation of gastroesophageal reflux disease. The experience of a center for digestive physiology in Southeastern Mexico.
        Rev Esp Enferm Dig. 2014; 106: 92-97
        • El-Serag H.B.
        • Petersen N.J.
        • Carter J.
        • et al.
        Gastroesophageal reflux among different racial groups in the United States.
        Gastroenterology. 2004; 126: 1692-1699
        • Herbella F.A.M.
        • Sweet M.P.
        • Tedesco P.
        • et al.
        Gastroesophageal reflux disease and obesity. Pathophysiology and implications for treatment.
        J Gastrointest Surg. 2007; 11: 286-290
        • Di Fede O.
        • Di Liberto C.
        • Occhipinti G.
        • et al.
        Oral manifestations in patients with gastro-oesophageal reflux disease: a single-center case-control study.
        J Oral Pathol Med. 2008; 37: 336-340
        • Malfertheiner P.
        • Hallerbäck B.
        Clinical manifestations and complications of gastroesophageal reflux disease (GERD).
        Int J Clin Pract. 2005; 59: 346-355
        • Ranjitkar S.
        • Smales R.J.
        • Kaidonis J.A.
        Oral manifestations of gastroesophageal reflux disease.
        J Gastroenterol Hepatol. 2012; 27: 21-27
        • Farrokhi F.
        • Vaezi M.F.
        Extra-esophageal manifestations of gastroesophageal reflux.
        Oral Dis. 2007; 13: 349-359
        • Sonnenberg A.
        • El-Serag H.B.
        Clinical epidemiology and natural history of gastroesophageal reflux disease.
        Yale J Biol Med. 1999; 72: 81-92
        • Richter J.E.
        What's new in gastroesophageal reflux disease for 2014.
        Gastroenterol Clin North Am. 2014; 43: xiii-xiv
        • Peery A.F.
        • Dellon E.S.
        • Lund J.
        • et al.
        Burden of gastrointestinal disease in the United States: 2012 update.
        Gastroenterology. 2012; 143 (1179–87.e1–3)
        • Giannini E.G.
        • Zentilin P.
        • Dulbecco P.
        • et al.
        Management strategy for patients with gastroesophageal reflux disease: a comparison between empirical treatment with esomeprazole and endoscopy-oriented treatment.
        Am J Gastroenterol. 2008; 103: 267-275
        • Spechler S.
        Barrett's esophagus: the American perspective.
        Dig Dis. 2013; 31: 10-16
        • Sharma N.
        • Ho K.Y.
        Risk factors for Barrett's oesophagus.
        Gastrointest Tumors. 2016; 3: 103-108
        • Duits L.C.
        • van der Wel M.J.
        • Cotton C.C.
        • et al.
        Patients with Barrett's esophagus and confirmed persistent low-grade dysplasia at increased risk for progression to neoplasia.
        Gastroenterology. 2017; 152: 993-1001.e1
        • Svoboda P.
        • Dítě P.
        • Klvaňa P.
        • et al.
        Risk factors and progression predictors of Barrett's oesophagus to adenocarcinoma.
        Vnitr Lek. 2014; 60: 467-473
        • Brimhall B.
        • Wani S.
        Current endoscopic approaches for the treatment of Barrett esophagus.
        J Clin Gastroenterol. 2017; 51: 2-11
        • Qureshi I.
        • Shende M.
        • Luketich J.
        Surgical palliation for Barrett's esophagus cancer.
        Surg Oncol Clin N Am. 2009; 18: 547-560
        • Katz P.O.
        • Gerson L.B.
        • Vela M.F.
        Guidelines for the diagnosis and management of gastroesophageal reflux disease.
        Am J Gastroenterol. 2013; 108: 308
        • De Groot N.L.
        • Burgerhart J.S.
        • Van De Meeberg P.C.
        • et al.
        Systematic review: the effects of conservative and surgical treatment for obesity on gastro-oesophageal reflux disease.
        Aliment Pharmacol Ther. 2009; 30: 1091-1102
        • Ness-Jensen E.
        • Hveem K.
        • El-Serag H.
        • et al.
        Lifestyle intervention in gastroesophageal reflux disease.
        Clin Gastroenterol Hepatol. 2016; 14 (175–82.e1–3)
        • Singh M.
        • Lee J.
        • Gupta N.
        • et al.
        Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: a prospective intervention trial.
        Obesity. 2013; 21: 284-290
        • Gawron A.J.
        • French D.D.
        • Pandolfino J.E.
        • et al.
        Economic evaluations of gastroesophageal reflux disease medical management.
        Pharmacoeconomics. 2014; 32: 745-758
        • Chey W.D.
        • Mody R.R.
        • Wu E.Q.
        • et al.
        Treatment patterns and symptom control in patients with GERD: US community-based survey.
        Curr Med Res Opin. 2009; 25: 1869-1878
        • Fass R.
        • Sifrim D.
        Management of heartburn not responding to proton pump inhibitors.
        Gut. 2009; 58: 295-309
        • Preetha A.
        • Sujatha D.
        • Patil B.A.
        • et al.
        Oral manifestations in gastroesophageal reflux disease.
        Gen Dent. 2015; 63: e27-e31
        • Lankarani K.B.
        • Sivandzadeh G.R.
        • Hassanpour S.
        Oral manifestation in inflammatory bowel disease: a review.
        World J Gastroenterol. 2013; 19: 8571-8579
        • Vasovic M.
        • Gajovic N.
        • Brajkovic D.
        • et al.
        The relationship between the immune system and oral manifestations of inflammatory bowel disease: a review.
        Cent Eur J Immunol. 2016; 41: 302-310
        • Jacobsen B.A.
        • Fallingborg J.
        • Rasmussen H.H.
        • et al.
        Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978-2002.
        Eur J Gastroenterol Hepatol. 2006; 18: 601-606
        • Loftus Jr., E.V.
        Update on the incidence and prevalence of inflammatory bowel disease in the United States.
        Gastroenterol Hepatol (N Y). 2016; 12: 704-707
        • Baumgart D.C.
        • Sandborn W.J.
        Crohn's disease.
        Lancet. 2012; 380: 1590-1605
        • Fatahzadeh M.
        Inflammatory bowel disease.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009; 108: e1-e10
        • Levine J.S.
        • Burakoff R.
        Extraintestinal manifestations of inflammatory bowel disease.
        Gastroenterol Hepatol (N Y). 2011; 7: 235-241
        • Lourenco S.V.
        • Hussein T.P.
        • Bologna S.B.
        • et al.
        Oral manifestations of inflammatory bowel disease: a review based on the observation of six cases.
        J Eur Acad Dermatol Venereol. 2010; 24: 204-207
        • Ghosh S.
        • Shand A.
        • Ferguson A.
        Ulcerative colitis.
        BMJ. 2000; 320: 1119-1123
        • Langan R.C.
        • Gotsch P.B.
        • Krafczyk M.A.
        • et al.
        Ulcerative colitis: diagnosis and treatment.
        Am Fam Physician. 2007; 76: 1323-1330
        • Ludwig D.
        • Stange E.F.
        Treatment of ulcerative colitis.
        Hepato-gastroenterology. 2000; 47: 83-89
        • Aggarwal A.
        • Sabol T.
        • Vaziri H.
        Update on the use of biologic therapy in ulcerative colitis.
        Curr Treat Options Gastroenterol. 2017; 15: 155-167
        • Elahi M.
        • Telkabadi M.
        • Samadi V.
        • et al.
        Association of oral manifestations with ulcerative colitis.
        Gastroenterol Hepatol Bed Bench. 2012; 5: 155-160
        • Tan C.X.
        • Brand H.S.
        • de Boer N.K.
        • et al.
        Gastrointestinal diseases and their oro-dental manifestations: part 1: Crohn's disease.
        Br Dent J. 2016; 221: 794-799
        • Femiano F.
        • Lanza A.
        • Buonaiuto C.
        • et al.
        Pyostomatitis vegetans: a review of the literature.
        Med Oral Patol Oral Cir Bucal. 2009; 14: E114-E117
        • Patil D.T.
        • Moss A.C.
        • Odze R.D.
        Role of histologic inflammation in the natural history of ulcerative colitis.
        Gastrointest Endosc Clin N Am. 2016; 26: 629-640
        • Matias Fde A.
        • Rosa D.J.
        • Carvalho M.T.
        • et al.
        Piodermatite-pioestomatite vegetante: relato de caso e revisão de literatura.
        An Bras Dermatol. 2011; 86: 137-140
        • Ruiz-Roca J.A.
        • Berini-Aytés L.
        • Gay-Escoda C.
        Pyostomatitis vegetans. Report of two cases and review of the literature.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005; 99: 447-454
        • Nico M.M.S.
        • Hussein T.P.
        • Aoki V.
        • et al.
        Pyostomatitis vegetans and its relation to inflammatory bowel disease, pyoderma gangrenosum, pyodermatitis vegetans, and pemphigus.
        J Oral Pathol Med. 2012; 41: 584-588
        • Siegel M.A.
        • Jacobson J.J.
        Inflammatory bowel diseases and the oral cavity.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999; 87: 12-14
        • Kreuter A.
        • Wieland U.
        Oral hairy leukoplakia: a clinical indicator of immunosuppression.
        CMAJ. 2011; 183: 932
        • Noonan V.
        • Woo S.B.
        • Kabani S.
        Pathology snapshot. Oral manifestations of Crohn's disease.
        J Mass Dent Soc. 2015; 64: 41
        • Podolsky D.K.
        Inflammatory bowel disease.
        N Engl J Med. 2002; 347: 417-429
        • Antunes H.
        • Patraquim C.
        • Baptista V.
        • et al.
        Oral manifestations of Crohn's disease.
        BMJ case Rep. 2015; 2015 ([pii: bcr2015212300])
        • Scheper H.J.
        • Brand H.S.
        Oral aspects of Crohn's disease.
        Int Dent J. 2002; 52: 163-172
        • Ghandour K.
        • Issa M.
        Oral Crohn's disease with late intestinal manifestations.
        Oral Surg Oral Med Oral Pathol. 1991; 72: 565-567
        • Harty S.
        • Fleming P.
        • Rowland M.
        • et al.
        A prospective study of the oral manifestations of Crohn's disease.
        Clin Gastroenterol Hepatol. 2005; 3: 886-891
        • Lemberg D.A.
        • Day A.S.
        Crohn disease and ulcerative colitis in children: an update for 2014.
        J Paediatr Child Health. 2015; 51: 266-270
        • Litsas G.
        Crohn's disease of the mouth: report of a case.
        Eur J Paediatr Dent. 2011; 12: 198-200
        • Siegel M.A.
        • Hupp W.S.
        Oral considerations in patients with gastrointestinal disorders. Chapter 7..
        in: Bayless T.M. Diehl A.M. Advanced therapy in gastroenterology and liver disease. 5th edition. B.C. Decker, Inc, Burlington (ON)2005: 43-48
        • Han M.
        • Fang H.
        • Li Q.L.
        • et al.
        Effectiveness of laser therapy in the management of recurrent aphthous stomatitis: a systematic review.
        Scientifica (Cairo). 2016; 2016: 9062430
        • Stricker T.
        • Braegger C.P.
        Images in clinical medicine. Oral manifestations of Crohn's disease.
        N Engl J Med. 2000; 342: 1644
        • Chavan M.
        • Jain H.
        • Diwan N.
        • et al.
        Recurrent aphthous stomatitis: a review.
        J Oral Pathol Med. 2012; 41: 577-583
        • Lakatos L.
        • Pandur T.
        • David G.
        • et al.
        Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study.
        World J Gastroenterol. 2003; 9: 2300-2307
        • Trost L.B.
        • McDonnell J.K.
        Important cutaneous manifestations of inflammatory bowel disease.
        Postgrad Med J. 2005; 81: 580-585
      1. Siegel M.A. Silverman S.S. Sollecito T.P. Clinicians guide to the treatment of common oral lesions. 6th edition. BC Decker, Hamilton (ON)2006: 57-61
      2. Michael G. Burket's oral medicine. 12th edition. 2015.

      3. Patton L. Glick M. Index in The ADA Practical Guide to Patients with Medical Conditions. 2nd edition. John Wiley & Sons, Inc, Hoboken (NJ)2015
        • Laranjeira N.
        • Fonseca J.
        • Meira T.
        • et al.
        Oral mucosa lesions and oral symptoms in inflammatory bowel disease patients.
        Arq Gastroenterol. 2015; 52: 105-110
        • Zbar A.P.
        • Ben-Horin S.
        • Beer-Gabel M.
        • et al.
        Oral Crohn's disease: is it a separable disease from orofacial granulomatosis? A review.
        J Crohns Colitis. 2012; 6: 135-142
        • Kim W.R.
        • Brown R.S.
        • Terrault N.A.
        • et al.
        Burden of liver disease in the United States: summary of a workshop.
        Hepatology. 2002; 36: 227-242
        • Glick M.
        Medical considerations for dental care of patients with alcohol-related liver disease.
        J Am Dent Assoc. 1997; 128: 61-70
        • Byron Jr., R.J.
        • Osborne P.D.
        Dental management of liver transplant patients.
        Gen dentistry. 2005; 53 ([quiz: 70–2]): 66-69
        • Wang F.S.
        • Fan J.G.
        • Zhang Z.
        • et al.
        The global burden of liver disease: the major impact of China.
        Hepatology. 2014; 60: 2099-2108
        • Younossi Z.M.
        • Stepanova M.
        • Afendy M.
        • et al.
        Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.
        Clin Gastroenterol Hepatol. 2011; 9 (524–30.e1)
        • Little J.W.
        • Falace D.A.
        • Miller C.S.
        • et al.
        Dental management of the medically compromised patient.
        8th edition. Mosby, St. Louis (MO)2013
        • Helenius-Hietala J.
        • Aberg F.
        • Meurman J.H.
        • et al.
        Oral surgery in liver transplant candidates: a retrospective study on delayed bleeding and other complications.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2016; 121: 490-495
        • Carrozzo M.
        • Scally K.
        Oral manifestations of hepatitis C virus infection.
        World J Gastroenterol. 2014; 20: 7534-7543
        • Hong C.H.
        • Scobey M.W.
        • Napenas J.J.
        • et al.
        Dental postoperative bleeding complications in patients with suspected and documented liver disease.
        Oral Dis. 2012; 18: 661-666
        • Guggenheimer J.
        • Close J.M.
        • Eghtesad B.
        • et al.
        Characteristics of oral abnormalities in liver transplant candidates.
        Int J Organ Transplant Med. 2010; 1: 107-113
        • Garcovich S.
        • Garcovich M.
        • Capizzi R.
        • et al.
        Cutaneous manifestations of hepatitis C in the era of new antiviral agents.
        World J Hepatol. 2015; 7: 2740-2748